11 reports

GLOBAL IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • World
  • Market Size

EUROPE IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • Europe
  • Market Size

NORTH AMERICA IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • North America
  • Market Size

LATIN AMERICA IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • Latin America
  • Market Size

ASIA PACIFIC IMMUNOHISTOCHEMISTRY MARKET FORECAST 2018-2026 ##.

  • Immunohistochemistry
  • APAC
  • Market Size

This has led to high demand of immunohistochemistry (IHC) products.

  • Immunohistochemistry
  • United States
  • Demand
  • Market Size

Strategic initiatives List of Tables ##.

  • Immunohistochemistry
  • In Vitro Diagnostics
  • United States
  • Demand
  • Market Size

Global Laboratory Reagents Industry LABORATORY REAGENTS MCP-## A GLOBAL STRATEGIC BUSINESS REPORT CONTENTS ##.

  • Immunohistochemistry
  • APAC
  • Japan
  • United States
  • World
  • GLOBAL IMMUNOHISTOCHEMISTRY MARKET SIZE, BY PRODUCT,
  • IMMUNOHISTOCHEMISTRY MARKET FOR DIAGNOSTIC APPLICATIONS

The immunohistochemistry (IHC) market is projected to reach USD 2.12 Billion by 2021, growing at a CAGR of 7.3% during the forecast period of 2016 to 2021. Factors such as the growing prevalence of cancer and rapidly increasing geriatric population across the globe are the primary driving the growth of this market. Other factors driving the...

  • Immunohistochemistry
  • North America
  • United States
  • World
  • Market Size
  • 7.2 IMMUNOHISTOCHEMISTRY (IHC)
  • IMMUNOHISTOCHEMISTRY TO FORM THE LARGEST TECHNOLOGY SEGMENT IN

“Global tissue diagnostics market projected to grow at a CAGR of 6.9% during the forecast period” The tissue diagnostics market is expected to reach USD 5.14 billion by 2022 from USD 3.68 billion in 2017, at a CAGR of 6.9%. Factors driving the growth of this market include the rising incidence of cancer, growing healthcare...

  • Immunohistochemistry
  • North America
  • United States
  • Market Size
  • Agilent Technologies, Inc.
  • IMMUNOHISTOCHEMISTRY BASED COMPANION DIAGNOSTIC KIT - MTX5
  • IMMUNOHISTOCHEMISTRY BASED COMPANION DIAGNOSTIC KIT - MTX3

Summary Oncomatryx Biopharma SL (Oncomatryx) is a developer of precision drugs.The company offers precision drugs that targets proteins located in the tumor environment. It develops therapeutic antibody-drug conjugates, antibodies, and human-derived proteins, which targets tumor associated stroma.Oncomatryx’s products...

  • Immunohistochemistry
  • In Vitro Diagnostics
  • United States
  • Company
  • Product Initiative